bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
- RxCUI
- 1294619
- RxNorm name
- bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
- Display name
- bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
- Full name
- bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PYLERA | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | H2-Pharma, LLC | 5cdacbf5-67be-42eb-bd54-8acc32ea1abc | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 1294619 |
| Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | H2-Pharma, LLC | c29bfde9-5eb4-422a-bd30-4bce45e73dc0 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 1294619 |
| Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | Par Health USA, LLC | c4d66e80-f0bc-4e64-a0f0-630ef673da1b | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 1294619 |
| PYLERA | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | H2-Pharma, LLC | c50626a2-5969-490b-a88a-a4ee45e79615 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | 1294619 |
| Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 4c7f024d-ba26-43cf-a36f-597e2168cd9f | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | 1294619 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c4d66e80-f0bc-4e64-a0f0-630ef673da1b | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule | SCD | 18 | These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE and TETRACYCLINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 2006 | 20260403 |
| c4d66e80-f0bc-4e64-a0f0-630ef673da1b | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule | PSN | 18 | These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE and TETRACYCLINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 2006 | 20260403 |
| c50626a2-5969-490b-a88a-a4ee45e79615 | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use Initial U.S. Approval: 2006 | 20260116 |
| c50626a2-5969-490b-a88a-a4ee45e79615 | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use Initial U.S. Approval: 2006 | 20260116 |
| 4c7f024d-ba26-43cf-a36f-597e2168cd9f | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 2006 | 20251111 |
| 4c7f024d-ba26-43cf-a36f-597e2168cd9f | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE capsules, for oral use Initial U.S. Approval: 2006 | 20251111 |
| 5cdacbf5-67be-42eb-bd54-8acc32ea1abc | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. PYLERA ® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use Initial U.S. Approval: 2006 | 20250407 |
| 5cdacbf5-67be-42eb-bd54-8acc32ea1abc | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. PYLERA ® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use Initial U.S. Approval: 2006 | 20250407 |
| c29bfde9-5eb4-422a-bd30-4bce45e73dc0 | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES, for oral use Initial U.S. Approval: 2006 | 20260413 |
| c29bfde9-5eb4-422a-bd30-4bce45e73dc0 | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES, for oral use Initial U.S. Approval: 2006 | 20260413 |
| 7fe5d2db-c59d-4e15-acd7-f9df8eca45aa | bismuth subcitrate 140 MG / metronidazole 125 MG / tetracycline hydrochloride 125 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 2006 | 20110203 |
| 7fe5d2db-c59d-4e15-acd7-f9df8eca45aa | bismuth subcitrate 140 MG / metroNIDAZOLE 125 MG / tetracycline HCl 125 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 2006 | 20110203 |